Clinical Trials Directory

Trials / Unknown

UnknownNCT01748331

The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia

The Significance of the Vasopressin System of the Hemodynamics, Water Balance and Prognosis in Chronic Heart Failure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Finn Gustafsson · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effect of fluid restriction and the neurohormonal mechanisms in the development of hyponatremia in patients with congestive heart failure and hyponatremia. The hypothesis is that strict fluid restriction leads to a larger increase in plasma sodium than standard treatment in patients with decompensated heart failure associated with hyponatremia. A secondary hypothesis is that the neurohormonal change is greater in patients treated with strict fluid restriction versus standard treatment.

Conditions

Interventions

TypeNameDescription
OTHERFluid restrictionPatients will be randomized to strict fluid restriction \< 1 L/day versus moderate fluid restriction \< 2.5 L/day

Timeline

Start date
2012-11-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2012-12-12
Last updated
2015-10-28

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01748331. Inclusion in this directory is not an endorsement.

The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia (NCT01748331) · Clinical Trials Directory